1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Liposome Drug Delivery Market – By product type
1.3.2 Europe Liposome Drug Delivery Market – By Technology
1.3.3 Europe Liposome Drug Delivery Market – By Application
1.3.4 Europe Liposome Drug Delivery Market – By Country
2. Liposome Drug Delivery Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Liposome Drug Delivery – Market Landscape
4.1 Overview
4.1.1 Europe– PEST Analysis
4.2 Expert Opinion
5. Europe Liposome Drug Delivery Market – Industry Dynamics
5.1 Market Drivers
5.1.1 Rising prevalence of Chronic Diseases
5.1.2 Growing Demand for Non-Invasive Drug Delivery Devices
5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
5.2 Market Restraints
5.2.1 High Cost Involved in Development of Drug Delivery Systems
5.3 Market Opportunities
5.3.1 Development of New Lipid Composition for Stability and Optimization of Drugs
5.4 Future Trends
5.4.1 Increasing Popularity of Liposomes in Drug Delivery
5.5 Impact Analysis
6. Liposome Drug Delivery Market –Asia Pacific Analysis
6.1 Europe Liposome Drug Delivery Market Revenue Forecast And Analysis
7. Liposome Drug Delivery Market Analysis – By Product
7.1 Overview
7.2 Liposome Drug Delivery Market Revenue Share, by Product (2019 and 2027)
7.3 Liposomal Doxorubicin
7.3.1 Overview
7.3.2 Liposomal Doxorubicin: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Liposomal Paclitaxel
7.4.1 Overview
7.4.2 Liposomal Paclitaxel: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Liposomal Amphotericin B
7.5.1 Overview
7.5.2 Liposomal Amphotericin B: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8. Liposome Drug Delivery Market – By Technology
8.1 Overview
8.2 Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
8.3 Stealth Liposome Technology
8.3.1 Overview
8.3.2 Stealth Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Non-PEGylated Liposome Technology
8.4.1 Overview
8.4.2 Non-PEGylated Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.5 DepoFoam Liposome Technology
8.5.1 Overview
8.5.2 Depo Foam Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Lysolipid Thermally Sensitive Liposome (LTSL) Technology
8.6.1 Overview
8.6.2 Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9. Liposome Drug Delivery Market – By Application
9.1 Overview
9.2 Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
9.3 Fungal Diseases
9.3.1 Overview
9.3.2 Fungal Diseases: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Cancer Therapy
9.4.1 Overview
9.4.2 Cancer Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Pain Management
9.5.1 Overview
9.5.2 Pain Management: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.6 Viral Vaccine
9.6.1 Overview
9.6.2 Viral Vaccine: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9.7 Photodynamic Therapy
9.7.1 Overview
9.7.2 Photodynamic Therapy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
10. Liposome Drug Delivery Market – Geographic Analysis
10.1 Europe: Liposome Drug Delivery Market
10.1.1 Overview
10.1.2 Europe: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 Europe Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.4 Europe Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.5 Europe Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.6 Europe: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
10.1.7 Germany: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Germany: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Germany Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 Germany Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 Germany Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.8 UK: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 UK: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 United Kingdom Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 United Kingdom Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 United Kingdom Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.9 France: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 France: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 France Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 France Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 France Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.10 Spain: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.1 Spain: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.2 Spain Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.10.3 Spain Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.10.4 Spain Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.11 Italy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.1 Italy: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.2 Italy Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.11.3 Italy Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.11.4 Italy Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)
11. Impact Of COVID-19 Pandemic On European Liposome Drug Delivery Market
11.1 Europe: Impact assessment of COVID-19 Pandemic
12. Liposome Drug Delivery Market –Company Profiles
12.1 Takeda Pharmaceutical Company Limited
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Novartis AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Luye Pharma Group
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Johnson & Johnson Services, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Ipsen Pharma
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Gilead Sciences, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Celsion, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Astellas Pharma Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms